Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma

Veterinary Immunology and Immunopathology

Volumn 121, Issue 3-4, 2008, Pages 241-250

  Reinero, Carol R ^a   Cohn, Leah A ^a   Delgado, Cherlene ^a   Spinka, Christine M ^b   Schooley, Elizabeth K ^a   DeClue, Amy E ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Animal model; CpG motifs; Eosinophilic inflammation; Hyposensitization; IgE; Immunomodulation

Indexed keywords

ALLERGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PLACEBO; THREONYLCYSTEINYLGLYCYLCYSTEINYLGLYCYLTHREONYLGLYCYLCYSTEINYL GLYCYLTHREONYLTHREONYLTHREONYLTHREONYLGLYCYLTHREONYLCYSTEINYLGLYCYL THREONYLTHREONYLTHREONYLTHREONYLGLYCYLALANYLCYSTEINYLGLYCYLTHREONYLTHREONINE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EOSINOPHIL; GRASS; IMMUNOTHERAPY; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; NONHUMAN;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CAT DISEASES; CATS; CYNODON; DESENSITIZATION, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FLOW CYTOMETRY; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES, REGULATORY;

ANIMALIA; CYNODON DACTYLON; FELIDAE;

EID: 38549132530     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.09.013     Document Type: Article

References (32)

1. Akbari O., Freeman G., Meyer E., Greenfield E., Chang T., Sharpe A., Berry G., DeKruyff R., and Umetsu D. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8 (2002) 1024-1032
2. Bluestone J., and Abbas A. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3 (2003) 253-257
3. Chakir J., Shannon J., Molet S., Fukakusa M., Elias J., Laviolette M., Boulet L., and Hamid Q. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-b, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111 (2003) 1293-1298
4. Cohn L., Elias J., and Chupp G. Asthma: mechanisms of disease persistence and progression. Ann. Rev. Immunol. 22 (2004) 789-815
5. Corcoran B., Foster D., and Fuentes V. Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats. J. Small Anim. Pract. 36 (1995) 481-488
6. Crimi E., Spanevello A., Neri M., Ind P., Rossi G., and Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 157 (1998) 4-9
7. Dye J., McKiernan B., Rozanski E., and Hoffmann W. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. J. Vet. Intern. Med. 10 (1996) 385-400
8. Fanucchi M., Schelegle E., Baker G., Evans M., McDonald R., Gershwin L., Raz E., Hyde D., Plopper C., and Miller L. Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys. Am. J. Respir. Crit. Care Med. 170 (2004) 1153-1157
9. Gauvreau G., Hessel E., Boulet L., Coffman R., and O'Byrne P. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am. J. Respir. Crit. Care Med. 174 (2006) 15-20
10. Hartmann G., Weeratna R., Ballas Z., Payette P., Suparto I., Rasmussen W., Waldschmidt M., Sajuthi D., Purcells R., Davis H., and Kreig A. Delineation of a CpG phophorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164 (2000) 1617-1624
11. Hawkins E., Kennedy-Stoskopf S., Levy J., Meuten D., Cullins L., DeNicola D., Tompkins W., and Tompkins M. Cytologic characterization of bronchoalveolar lavage fluid collected through an endotracheal tube in cats. Am. J. Vet. Res. 55 (1994) 795-802
12. Kibiki G., Myers L., Kalambo C., Hoang S., Stoler M., Stroup S., and Houpt E. Bronchoalveolar neutrophils, interferon gamma-inducible protein 10 and interleukin-7 in AIDS-associated tuberculosis. Clin. Exp. Immunol. 148 (2007) 254-259
13. Kline J., Waldschmidt T., Businga T., Lemish J., Weinstock J., Thorne P., and Kreig A. Cutting edge: modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160 (1998) 2555-2559
14. Kreig A. Therapeutic potential of toll-like receptor 9 activation. Nat. Rev. 5 (2006) 471-484
15. Larche M., Akdis C.A., and Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6 (2006) 761-771
16. Mangan N., van Rooijen N., McKenzie A., and Fallon P. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J. Immunol. 176 (2006) 138-147
17. Mills P., and Litster A. Using urea dilution to standardise cellular and non-cellular components of pleural and bronchoalveolar lavage (BAL) fluids in the cat. J. Feline Med. Surg. 8 (2006) 105-110
18. Moingeon P., Batard T., Fadel R., Frati F., Sieber J., and Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 61 (2006) 151-165
19. Moise N., Wiedenkeller D., and Yeager A. Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). J. Am. Vet. Med. Assoc. 194 (1989) 1467-1473
20. Norris Reinero C., Decile K., Berghaus R., Williams K., Leutenegger C., Walby W., Schelegle E., Hyde D., and Gershwin L. An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen. Int. Arch. Allergy Immunol. 135 (2004) 117-131
21. Ohman J. Allergen immunotherapy in asthma: evidence for efficacy. J. Allergy Clin. Immunol. 84 (1989) 133-140
22. Padrid P., Feldman B., Funk K., Samitz E., Reil D., and Cross C. Cytologic, microbiologic, and biochemical analysis of bronchoalveolar lavage fluid obtained from 24 healthy cats. Am. J. Vet. Res. 52 (1991) 1300-1307
23. Rankin R., Pontarollo R., Ioannou X., Krieg A., and Hecker R. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11 (2001) 333-340
24. Reinero C., Byerly J.R., Berghaus L., Hyde D.M., Schelegle E.S., and Gershwin L. Dissociation between airway inflammation and clinical signs of bronchoconstriction with CpG motifs in experimental feline asthma. In: 23rd Annual American College of Veterinary Internal Medicine Forum. Baltimore, MD (2005)
25. Reinero C., Decile K., Byerly J., Berghaus R., Walby W., Berghaus L., Hyde D., Schelegle E., and Gershwin L. Effect of drug therapy on airways inflammation and hyperreactivity, and immune parameters in a feline model of asthma. Am. J. Vet. Res. 66 (2005) 1121-1127
26. Reinero C.R., Byerly J.R., Berghaus R.D., Berghaus L.J., Schelegle E.S., Hyde D.M., and Gershwin L.J. Rush immunotherapy in an experimental model of feline allergic asthma. Vet. Immunol. Immunopathol. 110 (2006) 141-153
27. Robinson D., Hamid Q., Bentley A., Ying S., Kay A., and Durham S. Activation of CD4+ T cells, increased TH2-type cytolkine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92 (1993) 313-324
28. Romagnani S. The role of lymphocytes in allergic disease. J. Allergy Clin. Immunol. 105 (2000) 399-408
29. Stock P., Akbari O., DeKruyff R.H., and Umetsu D.T. Respiratory tolerance is inhibited by the administration of corticosteroids. J. Immunol. 175 (2005) 7380-7387
30. Umetsu D.T., and DeKruyff R.H. Immune dysregulation in asthma. Curr. Opin. Immunol. 18 (2006) 727-732
31. Umetsu D.T., and DeKruyff R.H. The regulation of allergy and asthma. Immunol. Rev. 212 (2006) 238-255
32. Yssel H., and Groux H. Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int. Arch. Allergy Immunol. 121 (2000) 10-18